JP2002527396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002527396A5 JP2002527396A5 JP2000575513A JP2000575513A JP2002527396A5 JP 2002527396 A5 JP2002527396 A5 JP 2002527396A5 JP 2000575513 A JP2000575513 A JP 2000575513A JP 2000575513 A JP2000575513 A JP 2000575513A JP 2002527396 A5 JP2002527396 A5 JP 2002527396A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrogen
- alkoxy
- alkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 description 18
- 239000001257 hydrogen Substances 0.000 description 18
- 150000002431 hydrogen Chemical class 0.000 description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- -1 Phenyl Chemical group 0.000 description 6
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000005191 hydroxyalkylamino group Chemical group 0.000 description 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10422698P | 1998-10-14 | 1998-10-14 | |
| US60/104,226 | 1998-10-14 | ||
| PCT/US1999/023900 WO2000021537A1 (en) | 1998-10-14 | 1999-10-14 | Novel indenoisoquinolines as antineoplastic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002527396A JP2002527396A (ja) | 2002-08-27 |
| JP2002527396A5 true JP2002527396A5 (https=) | 2006-12-14 |
| JP4580556B2 JP4580556B2 (ja) | 2010-11-17 |
Family
ID=22299324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000575513A Expired - Fee Related JP4580556B2 (ja) | 1998-10-14 | 1999-10-14 | 抗腫瘍薬である新規インデノイソキノリン類 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6509344B1 (https=) |
| EP (2) | EP1123099B1 (https=) |
| JP (1) | JP4580556B2 (https=) |
| AT (1) | ATE424204T1 (https=) |
| AU (1) | AU765135B2 (https=) |
| CA (1) | CA2347100C (https=) |
| DE (1) | DE69940523D1 (https=) |
| WO (1) | WO2000021537A1 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6956035B2 (en) * | 2001-08-31 | 2005-10-18 | Inotek Pharmaceuticals Corporation | Isoquinoline derivatives and methods of use thereof |
| US20030096833A1 (en) | 2001-08-31 | 2003-05-22 | Jagtap Prakash G. | Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| DE60235287D1 (de) * | 2001-11-14 | 2010-03-25 | Univ Rutgers | Löslich gemachte topoisomerase-gifte |
| EP1453812B1 (en) * | 2001-11-14 | 2008-08-20 | Rutgers, The State University | Cytotoxic agents |
| MXPA04004607A (es) | 2001-11-14 | 2004-09-10 | Univ Rutgers | Agentes de venenos de topoisomerasa solubilizados. |
| AU2002364953A1 (en) * | 2001-11-14 | 2003-06-17 | Edmond J. Lavoie | Topoisomerase poison agents |
| US6989387B2 (en) * | 2002-08-09 | 2006-01-24 | Rutgers, The State University Of New Jersey | Nitro and amino substituted topoisomerase agents |
| AU2003268075A1 (en) * | 2002-08-09 | 2004-02-25 | Edmond J. Lavoie | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents |
| US6992088B2 (en) * | 2002-08-09 | 2006-01-31 | Rutgers, The State University Of New Jersey | Nitro and amino substituted heterocycles as topoisomerase I targeting agents |
| CA2510337C (en) | 2002-11-12 | 2013-01-08 | Rutgers, The State University Of New Jersey | Topoisomerase-targeting agents |
| JP2007501857A (ja) * | 2003-02-28 | 2007-02-01 | イノテック ファーマシューティカルズ コーポレーション | 四環系ベンズアミド誘導体およびその使用方法 |
| EP1646388A4 (en) * | 2003-05-12 | 2007-04-18 | Purdue Research Foundation | CYTOTOXIC INDENO AND ISOINDOLOISOCHINOLONE |
| EA200601558A1 (ru) | 2004-02-26 | 2007-08-31 | Инотек Фармасьютикалз Корпорейшн | Производные изохинолинов и способы их использования |
| EP1735281A4 (en) * | 2004-03-17 | 2009-11-04 | Purdue Research Foundation | Synthesis of Indinoisoquinoline Compounds and Their Use |
| US7495100B2 (en) * | 2004-05-07 | 2009-02-24 | Purdue Research Foundation | Synthesis of indenoisoquinolines |
| RU2007135362A (ru) | 2005-02-25 | 2009-03-27 | Инотек Фармасьютикалз Корпорейшн (Us) | Тетрациклические амино- и карбоксамидосоединения и способ их применения |
| CN101316592A (zh) | 2005-08-24 | 2008-12-03 | 伊诺泰克制药公司 | 茚并异喹啉酮类似物及其用法 |
| US9399660B2 (en) | 2005-11-14 | 2016-07-26 | Purdue Research Foundation | N-substituted indenoisoquinolines and syntheses thereof |
| CA2629530C (en) | 2005-11-14 | 2014-07-08 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | N-substituted indenoisoquinolines and syntheses thereof |
| MX2009009183A (es) | 2007-02-28 | 2009-09-07 | Inotek Pharmaceuticals Corp | Analogos de indenoisoquinolinona y metodos de utilizacion de los mismos. |
| WO2010077663A2 (en) * | 2008-12-08 | 2010-07-08 | Inotek Pharmaceuticals Corporation | Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof |
| DK2403856T3 (da) | 2009-03-06 | 2013-04-08 | Univ Rutgers | Methylendioxybenzo[i]phenanthridinderivater anvendt til behandling af cancer |
| WO2010127363A1 (en) | 2009-05-01 | 2010-11-04 | Rutgers, The State University Of New Jersey | Toposiomerase inhibitors |
| WO2011094416A1 (en) * | 2010-01-27 | 2011-08-04 | Purdue Research Foundation | Substituted norindenoisoquinolines, syntheses thereof, and methods of use |
| US9073920B2 (en) | 2010-08-17 | 2015-07-07 | Purdue Research Foundation | Substituted dibenzonaphthyridines, pharmaceutical uses thereof and processes therfor |
| US9682990B2 (en) | 2011-05-25 | 2017-06-20 | Purdue Research Foundation | Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors |
| US9328073B2 (en) | 2011-05-25 | 2016-05-03 | Purdue Research Foundation | Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors |
| US8912213B2 (en) | 2012-04-13 | 2014-12-16 | Purdue Research Foundation | Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (TDP1)- topoisomerase I (TOP1) inhibitors |
| US9034870B2 (en) | 2012-07-13 | 2015-05-19 | Purdue Research Foundation | Azaindenoisoquinoline topoisomerase I inhibitors |
| US8686146B2 (en) | 2012-07-13 | 2014-04-01 | Purdue Research Foundation | Azaindenoisoquinoline topoisomerase I inhibitors |
| US10759795B2 (en) | 2016-03-15 | 2020-09-01 | Purdue Research Foundation | Aza-A-ring indenoisoquinoline topoisomerase I poisons |
| US11091498B2 (en) | 2016-04-04 | 2021-08-17 | Rutgers, The State University Of New Jersey | Topoisomerase poisons |
| US10875860B2 (en) | 2016-12-22 | 2020-12-29 | Purdue Research Foundation | Azaindenoisoquinoline compounds and uses thereof |
| US11311528B2 (en) * | 2018-03-20 | 2022-04-26 | Merck Sharp & Dohme Corp. | Oxo-tetrahydro-isoquinoline carboxylic acids as STING inhibitors |
| WO2020023700A2 (en) * | 2018-07-25 | 2020-01-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (Top1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (Tdp1) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3912740A (en) * | 1974-02-28 | 1975-10-14 | Us Health | Method for the preparation of oxygenated benzo{8 c{9 phenanthridine compounds |
| SK278794B6 (sk) * | 1991-08-29 | 1998-03-04 | V�Fb | 2-hydroxyetylaminosubstituované deriváty 5,11-diox |
| US5597831A (en) * | 1991-08-29 | 1997-01-28 | Vufb A.S | 6-[X-(2-hydroxyethyl) aminoalkyl]-5,11-dioxo-5,6-dihydro-11-H-indeno[1,2-c]isoquinolines and their use as antineoplastic agents |
| JP3141148B2 (ja) * | 1995-08-08 | 2001-03-05 | 大鵬薬品工業株式会社 | 縮合インダン誘導体及びその塩 |
| JP3643916B2 (ja) * | 1995-11-17 | 2005-04-27 | 大鵬薬品工業株式会社 | 新規な縮合インデン誘導体又はその塩 |
-
1999
- 1999-10-14 CA CA2347100A patent/CA2347100C/en not_active Expired - Fee Related
- 1999-10-14 AT AT99970323T patent/ATE424204T1/de not_active IP Right Cessation
- 1999-10-14 WO PCT/US1999/023900 patent/WO2000021537A1/en not_active Ceased
- 1999-10-14 DE DE69940523T patent/DE69940523D1/de not_active Expired - Lifetime
- 1999-10-14 AU AU12043/00A patent/AU765135B2/en not_active Ceased
- 1999-10-14 EP EP99970323A patent/EP1123099B1/en not_active Expired - Lifetime
- 1999-10-14 US US09/807,340 patent/US6509344B1/en not_active Expired - Lifetime
- 1999-10-14 EP EP09000858A patent/EP2050452A1/en not_active Withdrawn
- 1999-10-14 JP JP2000575513A patent/JP4580556B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002527396A5 (https=) | ||
| JP2002517491A5 (https=) | ||
| CA2440680A1 (en) | Steroids as agonists for fxr | |
| JP2002510633A5 (https=) | ||
| JP2002540208A5 (https=) | ||
| JP2001512743A5 (https=) | ||
| CA2405796A1 (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
| JP2002508362A5 (ja) | １−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体） | |
| JP2003528808A5 (https=) | ||
| JP2002542188A5 (https=) | ||
| JP2002519434A5 (https=) | ||
| JPWO2020123827A5 (https=) | ||
| JP2004508410A5 (https=) | ||
| JP2001526218A5 (https=) | ||
| CA2443623A1 (en) | A jasmonate pharmaceutical composition for treatment of cancer | |
| JP2003509349A5 (https=) | ||
| EP1442744A3 (en) | Use of EP4 receptor ligands in the treatment of, inter alia, neuropathic pain and colon cancer | |
| JP2002519425A5 (https=) | ||
| JP2003503449A5 (https=) | ||
| JP2003522198A5 (https=) | ||
| JP2005530852A5 (https=) | ||
| JP2002520286A5 (https=) | ||
| JP2004537498A5 (https=) | ||
| JP2001519413A5 (https=) | ||
| JP2005516898A5 (https=) |